Condition
Hodgkin Lymphoma (Category)
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
P 2 (3)
P 4 (1)
Trial Status
Not Yet Recruiting2
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06919679Phase 2Not Yet RecruitingPrimary
Phase II Trial of BrECADD in HIV-Positive Patients With Advanced-Stage Classical Hodgkin Lymphoma
NCT06761911Phase 4Not Yet RecruitingPrimary
BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma
NCT03527628Phase 2Unknown
OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy
NCT00003820Phase 2Completed
Rituximab in Treating Patients With Hodgkin's Lymphoma
Showing all 4 trials